Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism αvβ1 inhibitors(Integrin alpha-V/beta-1 inhibitors), αvβ8 inhibitors(Integrin αvβ8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 25 Apr 2024 | |
| Digestive System Disorders | Discovery | - | 25 Apr 2024 | |
| Dystrophy, Macular | Discovery | - | 25 Apr 2024 | |
| Encephalitis | Discovery | - | 25 Apr 2024 | |
| Myeloproliferative Disorders | Discovery | - | 25 Apr 2024 | |
| Neoplasms | Discovery | - | 25 Apr 2024 | |
| Osteoporosis | Discovery | - | 25 Apr 2024 | |
| Other Diseases | Discovery | - | 25 Apr 2024 | |
| Respiratory Diseases | Discovery | - | 25 Apr 2024 | |
| Retinal Vascular Disorder | Discovery | - | 25 Apr 2024 |





